Welcome to the webpage of the Teleki Research Group!
The laboratory of Associate Prof. Alexandra Teleki focuses on Pharmaceutical Nanotechnology in the area of Drug Development. The team works highly interdisciplinary to bridge biomarker discovery, nanomaterial and drug delivery system engineering to the manufacture of personalized dosage forms.
Our aim is to transform innovative nanomedical approaches to clinically relevant, patient-compliant diagnosis and treatment.
Our article on proteomics-informed identification of luminal targets for in situ diagnosis of IBD is online!
Here, we developed a robust method for rapid, medium throughput screening of intrinsic dissolution rate (IDR) and established the largest IDR dataset in open literature to date.
Alexandra Teleki receives 2 million euros from the European Research Council to develop a new method to diagnose and treat inflammatory bowel disease in children.